We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

166 hedge funds and large institutions have $1.05B invested in Momenta Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 68 increasing their positions, 44 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 44

45% more call options, than puts

Call options by funds: $3.76M | Put options by funds: $2.59M

44% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 18

5% more funds holding

Funds holding: 158 → 166 (+8)

23% less capital invested

Capital invested by funds: $1.36B → $1.05B (-$308M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
166
Holders Change
+8
Holders Change %
+5.06%
% of All Funds
3.76%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
26
Increased
68
Reduced
44
Closed
18
Calls
$3.76M
Puts
$2.59M
Net Calls
+$1.17M
Net Calls Change
-$1.84M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$20.7M
2
Millennium Management
Millennium Management
New York
+$10.4M
3
TAM
Tocqueville Asset Management
New York
+$9.24M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$5.3M
5
State Street
State Street
Massachusetts
+$5.05M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$13.3M
2
OM
Opaleye Management
Massachusetts
-$9.25M
3
Bank of America
Bank of America
North Carolina
-$8.4M
4
BIM
Bogle Investment Management
Massachusetts
-$6.91M
5
Fiera Capital (Canada)
Fiera Capital (Canada)
Quebec, Canada
-$6.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
GT
151
Glenmede Trust
Pennsylvania
$8K -$194K -14,340 -96%
FHA
152
First Horizon Advisors
Tennessee
$8K – – –
RA
153
Royce & Associates
New York
$8K +$8.22K +608 New
AG
154
Advisor Group
Arizona
$7K +$3.66K +271 +130%
IWP
155
Icon Wealth Partners
Texas
$6K +$6.25K +462 New
WAM
156
Wealthspire Advisors (Maryland)
Maryland
$5K +$1.92K +142 +59%
AC
157
Avestar Capital
New York
$4K +$4.2K +311 New
SEI Investments
158
SEI Investments
Pennsylvania
$2K – – –
SPIA
159
Steward Partners Investment Advisory
New York
$2K – – –
FANJ
160
Financial Architects (New Jersey)
New Jersey
$1K -$1.46K -108 -75%
CIM
161
Contravisory Investment Management
Massachusetts
$1K – – –
PFBT
162
Parkside Financial Bank & Trust
Missouri
$1K – – –
QCG
163
Quadrant Capital Group
Ohio
$1K – – –
TWA
164
TCI Wealth Advisors
Arizona
$1K – – –
CSS
165
Cubist Systematic Strategies
Connecticut
$1K +$1.35K +100 New
OM
166
Opaleye Management
Massachusetts
– -$9.25M -500,000 Closed
BIM
167
Bogle Investment Management
Massachusetts
– -$6.91M -373,408 Closed
TCM
168
Tekla Capital Management
Massachusetts
– -$2.83M -152,900 Closed
AC
169
Armistice Capital
New York
– -$2.44M -132,000 Closed
NFA
170
Nationwide Fund Advisors
Ohio
– -$2.01M -108,643 Closed
Los Angeles Capital Management
171
Los Angeles Capital Management
California
– -$1.14M -61,680 Closed
MC
172
Marcus Capital
Illinois
– -$932K -50,400 Closed
SG Americas Securities
173
SG Americas Securities
New York
– -$388K -20,988 Closed
FIM
174
Freedom Investment Management
Connecticut
– -$379K -20,463 Closed
WSCM
175
Wellington Shields Capital Management
New York
– -$372K -20,100 Closed
4 5 6
7
8

MNTA Hedge Fund Activity: Q4 2017 in Review

166 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2017, worth a combined $1.05B — down 23% from $1.36B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new MNTA positions and 18 closed out — a net gain of 8 holders — while 68 added to existing stakes and 44 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $20.7M. The largest seller was OrbiMed, cutting an estimated $13.3M.

  • 166 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2017, up from 158 in Q3 2017.
  • Funds reported $1.05B of Momenta Pharmaceuticals, Inc. stock for Q4 2017, down 23% quarter-over-quarter.
  • 26 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2017 and 18 closed out, a net change of +8 holders.
  • The largest Momenta Pharmaceuticals, Inc. buyer in Q4 2017 was Wellington Management Group, an estimated $20.7M added.
  • The largest Momenta Pharmaceuticals, Inc. seller in Q4 2017 was OrbiMed, an estimated $13.3M sold.

Based on aggregated 13F filings for Q4 2017.